Gufic Biosciences

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue173.66195.90215.20202.20195.87
Expenses149.73167.85184.26172.64168.76
EBITDA32.7736.3639.7136.8835.11
EBIT26.8532.1235.4132.7430.77
Profit Before Tax23.9428.0530.9529.5627.12
Net Profit18.1120.6223.2122.2620.05
Financial Ratios
Operating Profit Margin18.94%18.64%18.48%18.28%18.01%
Net Profit Margin10.47%10.57%10.80%11.03%10.28%
Earning Per Share (Diluted)1.872.132.392.232.00
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ